drugset / Trial / NCT01587313

A Comparison of Various Combinations of BiDil Capsules and BiDil Tablets in Healthy Human Volunteers

NCT01587313

Phase 1 Completed 36 enrolled Arbor Pharmaceuticals, Inc.
Non-randomizedCrossoverOpen-labelBasic science

Summary

This is a single center, open-label, two-period study. There will be nine healthy human volunteers arbitrarily assigned to one of four groups. The study objective is to compare the action of various combinations of BiDil extended-release capsules and commercial BiDil Tablets in the body over a period of time.

Timeline

Start
2012-04
Primary completion
2012-05
Completion
2012-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Hydralazine Small molecule
Subject Isosorbide Dinitrate Other / unclassified

Indications

No indication recorded.